Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

Conditions: Hyperinsulinism
Interventions: Drug: 18F-Fluoro Dopa PET/MRI Imaging
Sponsors: Washington University School of Medicine; St. Louis Children’s Hospital
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 20, 2025Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments